B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MITF

MOLECULAR TARGET

melanocyte inducing transcription factor

UniProt: O75030NCBI Gene: 428645 compounds

MITF (melanocyte inducing transcription factor) is targeted by 45 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MITF

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Cefdinir1.956
2Ethidium1.795
3Oxytetracycline1.795
4egcg1.614
5colchine1.614
6Anthralin1.393
7Aurintricarboxylic Acid1.393
8Biotin1.393
9Rolitetracycline1.393
10myricetin-3-O-galactopyranoside [Supplementary Concept]1.102
11Rutin1.102
12cycloheximide1.102
13Oxyphenbutazone1.102
14Topotecan1.102
15Methylene Blue0.691
16Rosmarinic Acid0.691
17Anisomycin0.691
18Astemizole Antihistamine drug now withdrawn from0.691
19Azacitidine0.691
20Azacitidine0.691
21Bortezomib0.691
22Calcimycin0.691
23Camptothecin0.691
24Carmine Coloring matter from0.691
25celastrol0.691
26Ciclopirox0.691
27clofilium tosylate0.691
28Demecolcine0.691
29Digitoxigenin 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide.0.691
30Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide.0.691
31Digoxin0.691
32Droxidopa0.691
33juglone hydroxylase [Supplementary Concept] catalyzes0.691
34Lanatosides Glycosides from DIGITALIS lanata leaf. Lanatoside C has actions similar to DIGOXIN. Mixtures of lanatosides A, B, and C have also been used. (From Martindale,0.691
35Levodopa0.691
36Niclosamide0.691
37Nocodazole Nocodazole is0.691
38pictilisib0.691
39Podophyllotoxin0.691
40Strophanthidin 3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20(22)-enolide.0.691
41torin 10.691
42tyrphostin 90.691
43vinblastine sulfate0.691
44Vincristine0.691
45Vorinostat0.691

About MITF as a Drug Target

MITF (melanocyte inducing transcription factor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 45 compounds with documented MITF interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MITF inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.